Hardik A. Shah

Patan, GJ, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Eustachian Tube Interventions in the Context of Chronic Otitis Media.

Eustachian Tube Interventions in the Context of Chronic Otitis Media.

Journal: Otolaryngologic clinics of North America

Published: July 24, 2026

Diagnostic Role of Complete Blood Count (CBC) and C-reactive Protein (CRP) in Suspected Early-Onset Sepsis and Antibiotic Stewardship in the Neonatal Intensive Care Unit (NICU).

Diagnostic Role of Complete Blood Count (CBC) and C-reactive Protein (CRP) in Suspected Early-Onset Sepsis and Antibiotic Stewardship in the Neonatal Intensive Care Unit (NICU).

Journal: Cureus

Published: July 16, 2026

Role of Pulse Oximetry Screening for Term Healthy Newborns During Transitional Period to Detect Critical Congenital Heart Disease (CCHD): A Prospective Observational Study in a Tertiary Care Hospital.

Role of Pulse Oximetry Screening for Term Healthy Newborns During Transitional Period to Detect Critical Congenital Heart Disease (CCHD): A Prospective Observational Study in a Tertiary Care Hospital.

Journal: Cureus

Published: May 11, 2026

'Survival and quality-of-life in mucormycosis'-author's reply.

'Survival and quality-of-life in mucormycosis'-author's reply.

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Published: July 08, 2025

Valorization of Rice-Bran and Corn-Flour Hydrolysates for Optimized Polyhydroxybutyrate Biosynthesis: Statistical Process Design and Structural Verification.

Valorization of Rice-Bran and Corn-Flour Hydrolysates for Optimized Polyhydroxybutyrate Biosynthesis: Statistical Process Design and Structural Verification.

Journal: Polymers

Published: June 23, 2025

Survival and quality-of-life in mucormycosis: a multicentric ambispective cohort study.

Survival and quality-of-life in mucormycosis: a multicentric ambispective cohort study.

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Published: February 04, 2025

Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1.

Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1.

Journal: Indian journal of ophthalmology

Published: June 22, 2021

Identification of a novel orally bioavailable NLRP3 inflammasome inhibitor.

Identification of a novel orally bioavailable NLRP3 inflammasome inhibitor.

Journal: Bioorganic & medicinal chemistry letters

Published: July 28, 2020

Discovery of N-Cyano-sulfoximineurea Derivatives as Potent and Orally Bioavailable NLRP3 Inflammasome Inhibitors.

Discovery of N-Cyano-sulfoximineurea Derivatives as Potent and Orally Bioavailable NLRP3 Inflammasome Inhibitors.

Journal: ACS medicinal chemistry letters

Published: September 19, 2019

Showing 1-9 of 9

Last Updated: 09/26/2026